"Supportive care" may hold less stigma than "palliative care"
the ONA take:
Hematologic specialists were less likely to refer patients early in the disease trajectory to palliative care and were conducive to referral with the service name supportive care instead of palliative care, a new study published online ahead of print in the journal The Oncologist has shown.
Because palliative care referrals are often delayed for patients with hematologic malignancies, researchers sought to examine the differences in attitudes and beliefs toward palliative care referral between hematologic and solid tumor specialists and how their perception was altered with the service name supportive care instead of palliative care.
For the study, researchers surveyed 120 hematologic and 120 solid tumor oncology specialists at University of Texas MD Anderson Cancer Center in Houston, Texas.
Results showed that hematologic specialists were less likely than solid tumor specialists to report that they would refer symptomatic patients with newly diagnosed cancer to palliative care.
Researchers also found that a significantly greater proportion of oncology specialists reported that they would refer a patient with newly diagnosed cancer to supportive care than palliative care, even though they both provide the same service.
“These findings suggest that rebranding might help to overcome the stigma associated with palliative care and improve patient access to palliative care services,” the authors conclude.
Hematologic specialists were less likely to refer patients early in the disease trajectory to palliative care.
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Cancer Risk Not Increased by Childhood Exposure to Diagnostic Radiation
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Immune Thrombocytopenia (Fact Sheet)
- Novel 3D Marker Reduces Radiation, Improves Cosmesis in Breast Conserving Surgery
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|